Refractory Epilepsy Clinical Trial
Official title:
Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)
Perampanel is a non-competitive antagonist of the AMPA (
2-amino-3-(5-méthyl-3-hydroxy-1,2-oxazol-4-yl)) propanoïc acid receptors which was approved
by the European Medicines Agency as adjunctive treatment for partial-onset seizures in
patients 12 years and older, in 2012. The aim of this study is to evaluate effectiveness and
safety of perampanel as add-on treatment in patients with refractory epilepsy.
The investigators retrospectively collected and analyzed the data of patients with
refractory epilepsy who had been treated with perampanel between May of 2014 and April of
2015. In total, one hundred and ten patients were included (mean age 41 [SD = 15.2]). The
mean duration of epilepsy was 25 years (SD = 14.4). The mean perampanel dose was 5.7 mg/d
(SD = 2.3). The retention rate was 77% at 6 months and 61% at 12 months. After 6 months, the
responder rate was 35.5%. Eight patients (7.3%) became seizure free. Adverse effects were
reported in 60 patients (54.5%). Most common side effects were behaviour disturbance
(22.7%), dizziness (15.5%), asthenia (11.8), somnolence (10%) and ataxia (9.1).
n/a
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02866240 -
Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy
|
N/A | |
| Withdrawn |
NCT04753983 -
A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy
|
N/A | |
| Completed |
NCT01899898 -
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05493722 -
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
|
Early Phase 1 | |
| Recruiting |
NCT03062514 -
Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy
|
N/A | |
| Recruiting |
NCT04770337 -
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
|
N/A | |
| Recruiting |
NCT05232630 -
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
|
Phase 4 | |
| Completed |
NCT04545346 -
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
|
N/A | |
| Not yet recruiting |
NCT04542629 -
Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
|
Phase 4 | |
| Terminated |
NCT03570489 -
Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy:
|
N/A | |
| Completed |
NCT05031208 -
Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy
|
N/A | |
| Completed |
NCT01880333 -
Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy
|
Phase 2/Phase 3 | |
| Completed |
NCT03676569 -
Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy
|
Phase 1 | |
| Withdrawn |
NCT03115489 -
Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus
|
Phase 2/Phase 3 | |
| Completed |
NCT01521754 -
Product Surveillance Registry- Deep Brain Stimulation for Epilepsy
|
||
| Recruiting |
NCT04684797 -
Localization of the Reward Positivity to ACC
|
N/A | |
| Completed |
NCT05292183 -
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
|
N/A | |
| Terminated |
NCT04398667 -
European Non-interventional Study on Refractory Epilepsy With Developmental Delay
|
||
| Active, not recruiting |
NCT04218812 -
Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation
|
N/A | |
| Terminated |
NCT02474407 -
Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
|
Phase 2 |